Recurrent or Refractory B-cell Non Hodgkin's Lymphoma
1 clinical trials · Condition
◉ Watch Recurrent or Refractory B-cell Non Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma (NCT06503211) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-31 |
Track Recurrent or Refractory B-cell Non Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.